JournalsHub
.online
Find My Journal
KR

Kyla Ramey

Gilead Sciences (United States) US

1
Publications
85
Citations
1
H-Index
1
i10-Index
0
2yr Mean Cite
True
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®
James G. Taylor, Sheila Zipfel, Kyla Ramey, Randy Vivian, Adam J. Schrier +21 more
Bioorganic & Medicinal Chemistry Letters 2019
85

Publications

1 total

Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®

James G. Taylor, Sheila Zipfel, Kyla Ramey, Randy Vivian, Adam J. Schrier et al. - Bioorganic & Medicinal Chemistry Letters, 2019
Cited by 85 OpenAlex

Research Topics

Hepatitis C virus research (1) HIV/AIDS drug development and treatment (1) Biochemical and Molecular Research (1)

Frequent Co-Authors

JA
James G. Taylor
1 joint publication
SH
Sheila Zipfel
1 joint publication
RA
Randy Vivian
1 joint publication
AD
Adam J. Schrier
1 joint publication
KA
Kapil Karki
1 joint publication
AS
Ashley A. Katana
1 joint publication

Affiliations

Gilead Sciences (United States)
US 2019 - 2019

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now